PhRMA selects AdvaMed's Ubl as next CEO
- October 2, 2015 |
- Walt Williams
Medical device CEO shifts to prescription drugs Ubl Stephen Ubl has been named the next CEO of Pharmaceutical Research and Manufacturers of America, replacing John Castellani, who will retire at the end of the year. Ubl currently is CEO of the Advanced Medical Technology Association, a Washington, D.C.-based trade group representing companies that produce medical devices and health information systems. In making the switch to PhRMA, Ubl joins an organization not only six times the size of AdvaMed in revenue, but that also is one of the most powerful advocacy groups in the nation's capital. In a statement, Ubl did not indicate in what direction he would take the… Read More